Often, drug development has focused on minute agents, but amino acid alliances are progressively receiving momentum. This new approach utilizes combining peptidic sequences with alternative therapeutic techniques to tackle challenging illness targets. By employing the distinctive properties of peptides – such as high precision and delivery – in